Literature DB >> 34225577

"Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer.

Marion Avril1, R William DePaolo1,2.   

Abstract

Colorectal cancer (CRC) is a significant public health problem accounting for about 10% of all new cancer cases globally. Though genetic and epigenetic factors influence CRC, the gut microbiota acts as a significant component of the disease's etiology. Further research is still needed to clarify the specific roles and identify more bacteria related to CRC development. This review aims to provide an overview of the "driver-passenger" model of CRC. The colonization and active invasion of the "driver(s)" bacteria cause damages allowing other commensals, known as "passengers," or their by-products, i.e., metabolites, to pass through the epithelium . This review will not only focus on the species of bacteria implicated in this model but also on their biological functions implicated in the occurrence of CRC, such as forming biofilms, mucus, penetration and production of enterotoxins and genotoxins.

Entities:  

Keywords:  Colorectal cancer; biofilm; driver-passenger; metabolites; microbiome; mucus

Mesh:

Substances:

Year:  2021        PMID: 34225577      PMCID: PMC8265790          DOI: 10.1080/19490976.2021.1941710

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  111 in total

Review 1.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

2.  Desulfovibrio bacterial species are increased in ulcerative colitis.

Authors:  Fiachra Rowan; Neil G Docherty; Madeline Murphy; Brendan Murphy; John Calvin Coffey; P Ronan O'Connell
Journal:  Dis Colon Rectum       Date:  2010-11       Impact factor: 4.585

3.  Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.

Authors:  Mara Roxana Rubinstein; Jung Eun Baik; Stephen M Lagana; Richard P Han; William J Raab; Debashis Sahoo; Piero Dalerba; Timothy C Wang; Yiping W Han
Journal:  EMBO Rep       Date:  2019-03-04       Impact factor: 8.807

Review 4.  Immune adaptations that maintain homeostasis with the intestinal microbiota.

Authors:  Lora V Hooper; Andrew J Macpherson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

5.  Association between Helicobacter pylori infection and colorectal neoplasm risk: a meta-analysis based on East Asian population.

Authors:  Yu Guo; Hai-Yan Li
Journal:  J Cancer Res Ther       Date:  2014-12       Impact factor: 1.805

6.  Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice.

Authors:  Ho Tsoi; Eagle S H Chu; Xiang Zhang; Jianqiu Sheng; Geicho Nakatsu; Siew C Ng; Anthony W H Chan; Francis K L Chan; Joseph J Y Sung; Jun Yu
Journal:  Gastroenterology       Date:  2017-01-23       Impact factor: 22.682

Review 7.  Influence of obesity on the risk of developing colon cancer.

Authors:  E E Frezza; M S Wachtel; M Chiriva-Internati
Journal:  Gut       Date:  2005-10-20       Impact factor: 23.059

Review 8.  The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases.

Authors:  Christine C Johnson; Dennis R Ownby
Journal:  Transl Res       Date:  2016-07-09       Impact factor: 7.012

Review 9.  Oxidative Stress and the Microbiota-Gut-Brain Axis.

Authors:  Laura Dumitrescu; Iulia Popescu-Olaru; Liviu Cozma; Delia Tulbă; Mihail Eugen Hinescu; Laura Cristina Ceafalan; Mihaela Gherghiceanu; Bogdan Ovidiu Popescu
Journal:  Oxid Med Cell Longev       Date:  2018-12-09       Impact factor: 6.543

10.  Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.

Authors:  Maelle Prorok-Hamon; Melissa K Friswell; Abdullah Alswied; Carol L Roberts; Fei Song; Paul K Flanagan; Paul Knight; Caroline Codling; Julian R Marchesi; Craig Winstanley; Neil Hall; Jonathan M Rhodes; Barry J Campbell
Journal:  Gut       Date:  2013-07-11       Impact factor: 23.059

View more
  11 in total

1.  The comparison of microbial communities in thyroid tissues from thyroid carcinoma patients.

Authors:  Chen-Jian Liu; Si-Qian Chen; Si-Yao Zhang; Jia-Lun Wang; Xiao-Dan Tang; Kun-Xian Yang; Xiao-Ran Li
Journal:  J Microbiol       Date:  2021-10-06       Impact factor: 3.422

Review 2.  Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention.

Authors:  Wenjie Zhang; Jie Zhang; Tian Liu; Juan Xing; Huan Zhang; Daorong Wang; Dong Tang
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-04       Impact factor: 4.322

Review 3.  The role of microbiota in colorectal cancer.

Authors:  Azar Dokht Khosravi; Sakineh Seyed-Mohammadi; Ali Teimoori; Aram Asarehzadegan Dezfuli
Journal:  Folia Microbiol (Praha)       Date:  2022-05-10       Impact factor: 2.629

Review 4.  Microbial influences on gut development and gut-brain communication.

Authors:  Lihua Ye; John F Rawls
Journal:  Development       Date:  2021-11-10       Impact factor: 6.862

Review 5.  Gut microbiome: New biomarkers in early screening of colorectal cancer.

Authors:  Peng Zhou; Dongxue Yang; Desen Sun; Yuping Zhou
Journal:  J Clin Lab Anal       Date:  2022-03-21       Impact factor: 3.124

6.  Intestinal inflammation and the microbiota: Beyond diversity.

Authors:  Gabriela Gama Freire Alberca; Naiane Samira Souza Cardoso; Rosa Liliana Solis-Castro; Viviane Nakano; Ricardo Wesley Alberca
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

7.  Crosstalk between mucosal microbiota, host gene expression, and sociomedical factors in the progression of colorectal cancer.

Authors:  Namjoo Kim; Jeong-An Gim; Beom Jae Lee; Byung Il Choi; Hee Sook Yoon; Seung Han Kim; Moon Kyung Joo; Jong-Jae Park; Chungyeul Kim
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

Review 8.  Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer.

Authors:  Hua-Zhong Ying; Wei Xie; Meng-Chuan Wang; Jia-Qi He; Huan-Huan Zhang; Chen-Huan Yu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-16       Impact factor: 6.073

9.  Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism.

Authors:  Yaxin Zhang; Yuyan Gu; Jing Jiang; Xiaobing Cui; Saibo Cheng; Linling Liu; Zhiyong Huang; Rongxin Liao; Peng Zhao; Jieying Yu; Jing Wang; Yuhua Jia; Wen Jin; Fenghua Zhou
Journal:  NPJ Sci Food       Date:  2022-08-27

Review 10.  The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis.

Authors:  Natalia N Markelova; Elena F Semenova; Olga N Sineva; Vera S Sadykova
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.